IMPACT. MAKE ONE.

Help us prevent the preventable, treat the treatable, and put an end to breast cancer forever.

Get Involved!

Join Us: Capital Day for the Cure - May 9, 2013

Save the Date: Race for the Cure CenLA October 19, 2013

SUSAN G. KOMEN ANNOUNCES COMMUNITY GRANT AWARD RECIPIENTS
Grants will support critical screening programs available to uninsured and underinsured populations within our affiliate's six parish service area, including Acadia, Iberia, Lafayette, St. Landry, St. Martin and Vermilion. .
More

Komen Acadiana Hosting First Volunteer Training of the Year
Komen Ambassadors will be trained to attend local health fairs, community, church and school presentations. Registration to attend upcoming training is due April 15, 2013. .
More

RACE FOR THE CURE PRESENTING SPONSOR, CYPRESS BAYOU CASINO PRESENTS VIPink
Cypress Bayou Casino and Hotel, a presenting sponsor of Race for the Cure, will host VIPink, a gala event to celebrate the success and fundraising efforts of Race for the Cure participants, Saturday, April 13, in Baldwin, LA. .
More

Get Involved!

Join Us: Capital Day for the Cure - May 9, 2013

Save the Date: Race for the Cure CenLA October 19, 2013

Learn More

Have you Been Tested?

Screening is a method of detectingcancer early before symptoms occur. Find out today if you qualify for Free screenings.

View Upcoming Screening Dates

Banking on a promise

Haven’t you always wanted to show the Acadiana Affiliate of Susan G. Komen for the Cure® ribbon wherever you go? Well, now is your chance. Learn how Bank of America is supporting our promise with uniquely designed credit cards, debit cards and checks.

Learn More

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.